NDTV Profit's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset managers and research agencies. These reports offer NDTV Profit's subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Systematix Research Report
EPL Ltd. management reiterated its vision of becoming the “most sustainable packaging company in the world” at its recent plant visit. It leads the conversion of sustainable tube supplies, having sold 25-30 million PCR (post-consumer recycled material) tubes last year.
-
Indian Markets Turning Corner After Two Tough Years, Says Sandeep Tandon -
NDTV Profit Ignite 2026: Experts See Opportunity In Equities, Stay Bullish For Long-Term -
Buy Right, Sit Tight Does Not Work for Individual Stocks, Says Dinshaw Irani -
'Worst Is Behind': Quant MF Sees Market Bottom, Flags 'Extreme Euphoria' In Midcaps -
India's Mutual Fund Industry Could Become A $1 Trillion Opportunity, Say Fund Managers -
'Foreign Investors Are Baraatis': Raamdeo Agrawal's Take On LTCG Tax -
Stay Invested Through Market Cycles: Raamdeo Agrawal at NDTV Profit Ignite -
Ramesh Damani Remains Bullish On India For Next 20-30 Years, Sees Bargains Amid Market Weakness -
CAS Came After A Long Consultation Process: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFIT IGNITE -
Aim To Cut FPI Onboarding Time From Mth To Five Days: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFI
Management expects 75-80% of the industry to move to PCR tubes over the next one-two years, except in pharma, where regulations are stringent. EPLL surpassed its target of doubling sustainable tubes volumes in FY24 (up 21% YoY) and expects to triple volumes in the next three years.
Also Read | Layoffs Are Rising In Tech, But These Skills Are Helping People Unlock Better Pay
EPL's strategy is to accelerate the conversion process and gain wallet share. Its long-term focus is to deliver profitable growth through a four-point strategy-
accelerate growth in beauty and cosmetics and pharma,
build wallet share in all key markets,
lead sustainability and inspire customers to turn sustainable, and
drive multi-year projects to harness ‘fuel for growth'.
For FY25, management expects to achieve healthy volume growth and improve margins across geographies. Management reiterated its double-digit revenue growth guidance and is confident of clocking 20% Ebitda margin in FY25.
Reiterating Buy with a target price of Rs 264 (unchanged), based on 20 times FY26E P/E (unchanged).
Key risks: Global recession could keep demand subdued, spike in commodity prices.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
